One study using the transplantable TRAMP-C2 mouse prostate carcinoma model34 showed that cryotherapy in combination with anti-CTLA-4 ICI was associated with reduced tumor burden during a second tumor re-challenge35. This evidence concerns the gene CTLA4 and prostate carcinoma.